{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/123-US9,535,057(active).pdf"}, "page_content": "U.S. Patent\n\nJan. 3, 2017\n\nSheet 4 of 5\n\nUS 9,535,057 B2\n\nOO O 1\n\nO. O\n\nO. O\n\nO.O\n\nO.2\n\n0.4\n\nO.6\n\nO.8\n\n1.O\n\nRhythmicity Index\n\nFigure 6.\n\nU.S. Patent\n\nUS 9,535,057 B2\n\nJan. 3, 2017\n\nSheet 4 of 5\n\nSD of heart OQ CD o oO \u5716 \u5df2 0.0 0.2 0.4 0.6 0.8 1.0 Rhythmicity Index\n\nFigure 6.\n\nU.S. Patent\n\nJan. 3, 2017\n\nSheet 5 of 5\n\nUS 9,535,057 B2\n\n150\n\n2.5\n\no\n\nN\n\nt\n\nE 2.0\n\no 100\n\n15\n\nS\n\ns\n\n10\n\n5\n\ny\n\n5 0.5\n\nG\n\nO.O\n\nControl\n\nHaloperidol\n\nContro\n\nHaloperidol\n\nFigure 7.\n\n1.\n\nr\n\nx 100\n\n0.03\n\n0.75\n\nk\n\nAp\n\ne\n\n0.02\n\n0.50\n\n()\n\n::\"\n\n0.01\n\n0.25\n\nO\n\n0.00\n\n0.00\n\nControl\n\nHaloperidol\n\nControl\n\nHaloperidol\n\nFigure 8.\n\nU.S. Patent\n\nUS 9,535,057 B2\n\nJan. 3, 2017\n\nSheet 5 of 5\n\n\u4e00 150 \u4e8c 2.5 \u4e0a N = * = 2.0 \u54e1 > 100, tJ Dis i So 80 \u4e0a \u6642 \u548c \u540c 0.5. 2 a = 6. 0.0 Controt Haloperidot Controt Haloperidol\n\nFigure 7.\n\n1.00 2 Q a \u4eba e & 5 3 & > \u4e0a 2 E \u00a3 \u6240 \u4e09 4 2 8 Control Haloperido} Control Haloperidol\n\nUS 9,535,057 B2\n\n1.\n\n2\n\nZebrafish has emerged as a model in developmental\n\nMETHOD OF IN VIVO SCREENING FOR\n\nbiology studies, toxicology studies as well as pharmaceuti\n\nCARDAC TOXC AGENTS USING TELEOST\n\ncal studies. Zebrafish in vivo bioassay combines the advan\n\ntages of high throughput, as compared to mammalian in vivo\n\nFIELD OF THE INVENTION\n\nassays, and high relevance, as compared to in vitro assays.\n\nRecently, two articles have been published demonstrating\n\nCardiac arrhythmia, a group of conditions in which the\n\nheart beat is going too fast (tachyrhythmia), too slow or\n\nsimilar physiological responses of Zebrafish to well-know\n\nirregularly (bradyrhythmia), is a life-threatening medical\n\ncompounds that induce cardiac arrhythmia in humans\n\n(Langheinrich et al. 2003; Milan et al. 2003). Furthermore,\n\nemergency that causes cardiac arrest and Sudden death\n\nthe ortholog of hERG was cloned and showed high simi\n\n(Kleber and Rudy. 2004). The common causes for both\n\n10\n\nlarity in protein sequence in the pore region and the cyclic\n\ncongenital and acquired cardiac arrhythmia are genetic and", "type": "Document"}}